Mayo Clinic Study Identifies Mechanism Behind Immunotherapy Resistance in Lung Cancer

Mayo Clinic Study Identifies Mechanism Behind Immunotherapy Resistance in Lung Cancer

Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, helping explain why many patients do not respond to immunotherapy and pointing to a potential new approach to make those treatments more effective.

Mayo Clinic Study Uncovers Mechanism Driving Immunotherapy Resistance in

In a groundbreaking discovery poised to reshape the landscape of lung cancer treatment, researchers at Mayo Clinic have elucidated a previously unrecognized mechanism by which lung tumors sabotage the immune system. This insight not only sheds light on why many lung cancer patients exhibit resistance to immunotherapy but also unveils a promising therapeutic target that could enhance the efficacy of current cancer immunotherapies. The study, feat…